Medical Data Vision Co., Ltd. (MDV, listed on the Tokyo Stock Exchange Prime Market, 3902; Head Office: Chiyoda-ku, Tokyo; President: Hiroyuki Iwasaki) will participate at ACPE 2025, the 17th Asian Conference on Pharmacoepidemiology, hosted by the International Society for Pharmacoepidemiology (ISPE) and taking place from November 21 to 23, 2025, at The University of Hong Kong, Hong Kong.
ACPE is a leading pharmacoepidemiology and pharmacovigilance conference in Asia, bringing together researchers, healthcare professionals, and policymakers from across Asia and around the world.
MDV will have a booth at ACPE 2025, showcasing its real-world evidence (RWE) capabilities, healthcare data assets, and analytics solutions. We warmly invite all attendees to visit our booth and discuss opportunities for collaboration in pharmacoepidemiology and drug safety research.
